Mualliflar

  • Хамраева У.Ш., Каримова М.Х.

##semicolon##

Синдром Дауна, ультразвуковое Б-сканирование, патологии стекловидного тела, биологическое старение витреума.

##submission.citations##

1. Beresford-Webb JA, Charlesworth E, Pardhan S, Wang V, Vaughan M, Igbineweka M, Zaman SH. The Ocular Manifestations of Individuals With Down Syndrome: A Systematic Review and Meta-Analysis. J Ophthalmol. 2025 Mar 18;2025:2317959. doi: 10.1155/ joph/2317959. PMID: 40134611; PMCID: PMC11936530.

2. Sun E, Kraus CL. The Ophthalmic Manifestations of Down Syndrome. Children (Basel). 2023 Feb 9;10(2):341. doi: 10.3390/ children10020341. PMID: 36832470; PMCID: PMC9955748.

3. De La Hoz Polo M, Torramilans Lluís A, Pozuelo Segura O, Anguera Bosque A, Esmerado Appiani C, Caminal Mitjana JM. Ocular ultrasonography focused on the posterior eye segment: what radiologists should know. Insights Imaging. 2016 Jun;7(3):351-64. doi: 10.1007/s13244-016-0471-z. Epub 2016 Feb 24. PMID: 26910565; PMCID: PMC4877345.

4. Spitzer MS, Januschowski K. Gesunder Glaskörper und seine Alterung [Aging and age-related changes of the vitreous body]. Ophthalmologe. 2015 Jul;112(7):552, 554-8. German. doi: 10.1007/s00347-015-0031-9. PMID: 26002378.

5. Leonoor I. Los, Roelofje J. van der Worp, Marja J. A. van Luyn, Johanna M. M. Hooymans; Age-Related Liquefaction of the Human Vitreous Body: LM and TEM Evaluation of the Role of Proteoglycans and Collagen. Invest. Ophthalmol. Vis. Sci. 2003;44(7):2828-2833. https://doi.org/10.1167/iovs.02-0588.

6. Los LI, van der Worp RJ, van Luyn MJ, Hooymans JM. Age-related liquefaction of the human vitreous body: LM and TEM evaluation of the role of proteoglycans and collagen. Invest Ophthalmol Vis Sci. 2003 Jul; 44(7): 2828-33. doi: 10.1167/iovs.02-0588. PMID: 12824219.

7. Gensous N, Bacalini MG, Franceschi C, Garagnani P. Down syndrome, accelerated aging and immunosenescence. Semin Immunopathol. 2020 Oct;42(5):635-645. doi: 10.1007/s00281-020-00804-1. Epub 2020 Jul 23. PMID: 32705346; PMCID: PMC7666319.

8. Horvath S., Garagnani P., Giulia M., Pirazzini C., Salvioli S., Gentilini D., Di Blasio A., Giuliani C., Tung S., Vinters H., Franceschi C.. Accelerated epigenetic aging in Down syndrome. Aging CellVolume 2015 Feb. 14, Issue 3 pp. 491-495. https://doi.org/10.1111/acel. 12325

9. Rodríguez-Sureda V, Vilches Á, Sánchez O, Audí L, Domínguez C. Intracellular oxidant activity, antioxidant enzyme defense system, and cell senescence in fibroblasts with trisomy 21. Oxid Med Cell Longev. 2015; 2015:509241. doi: 10.1155/2015/509241. Epub 2015 Mar 17. PMID: 25852816; PMCID: PMC4380103.

10. Kato Y, Yamamoto T. Eruptive collagenoma in a juvenile patient with Down syndrome. An Bras Dermatol. 2022 Sep-Oct; 97(5):687-688. doi: 10.1016/j.abd.2020.10. 026. Epub 2022 Jul 9. PMID: 35820949; PMCID: PMC9453520.

11. Garcia-Aguirre G, Henaine-Berra A, Salcedo-Villanueva G. Visualization and Grading of Vitreous Floaters Using Dynamic Ultra-Widefield Infrared Confocal Scanning Laser Ophthalmoscopy: A Pilot Study. J Clin Med. 2022 Sep 20;11(19):5502. doi: 10.3390/jcm1 1195502. PMID: 36233369; PMCID: PMC9571 201.

12. Son G, Sohn J, Kong M. Acute symptomatic vitreous floaters assessed with ultra-wide field scanning laser ophthalmoscopy and spectral domain optical coherence tomography. Sci Rep. 2021 Apr 26;11(1):8930. doi: 10. 1038/s41598-021-88371-9. PMID: 339036 57; PMCID: PMC8076170.

13. Haseeb A, Huynh E, ElSheikh RH, ElHawary AS, Scelfo C, Ledoux DM, Maidana DE, Elhusseiny AM. Down syndrome: a review of ocular manifestations. Ther Adv Ophthalmol. 2022 Jun 30;14:25158414221101718. doi: 10.1177/25158414221101718. PMID: 35795 721; PMCID: PMC9252013.

14. Badr O. AlAhmadi, Sulaiman M. Alsulaiman, J. Fernando Arevalo Retinal Detachment in Down Syndrome: Characteristics and Surgical Outcomes. Journal of OphthalmologyVolume 2016, Issue 1 6971591. March 20 16. https://doi.org/10.1155/2016/697 159

15. Prakhunhungsit S, Berrocal AM. Diagnostic and Management Strategies in Patients with Persistent Fetal Vasculature: Current Insights. Clin Ophthalmol. 2020 Dec 10; 14:4325-4335. doi: 10.2147/OPTH.S236117. PMID: 33335385; PMCID: PMC7737165.

16. Yonemoto Y, Morishita S, Fukumoto M, Mimura M, Sato T, Kida T, Kojima S, Oku H, Sugasawa J, Ikeda T. Bilateral rhegmatogenous retinal detachment due to unusual retinal degeneration in Down syndrome: A case report. Medicine (Baltimore). 2018 Jun; 97 (22): e10896. doi: 10.1097/MD.0000000000 010896. PMID: 29851814; PMCID: PMC6392 586.

17. Mathan J., Simkin S., Gokul A., McGhee Ch. Down syndrome and the eye: Ocular characteristics and ocular assessment. Survey of Ophthalmology, Volume 67, Issue 6, 2022. Pages 1631-1646, ISSN 0039-6257. https://doi.org/10.1016/j.survophthal.2022.03.006.

18. Gill N, Singh A. Management of Visually Significant Vitreous Opacities. Mo Med. 2024 Sep-Oct; 121(5):391-394. PMID: 3942 1475; PMCID: PMC11482840.

19. Mamou J, Wa CA, Yee KM, Silverman RH, Ketterling JA, Sadun AA, Sebag J. Ultrasound-based quantification of vitreous floaters correlates with contrast sensitivity and quality of life. Invest Ophthalmol Vis Sci. 2015 Jan 22;56(3):1611-7. doi: 10.1167/iovs.14-15414. PMID: 25613948; PMCID: PMC4554 261.